New cases of progressive multifocal leukoencephalopathy after treatment with natalizumab
- 1 January 2009
- journal article
- Published by Elsevier in The Lancet Neurology
- Vol. 8 (1) , 28-31
- https://doi.org/10.1016/s1474-4422(08)70281-3
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- Influence of HAART on the Clinical Course of HIV-1-Infected Patients With Progressive Multifocal Leukoencephalopathy: Results of an Observational Multicenter StudyJAIDS Journal of Acquired Immune Deficiency Syndromes, 2008
- Natalizumab for Multiple SclerosisNew England Journal of Medicine, 2007
- Natalizumab treatment for multiple sclerosis: recommendations for patient selection and monitoringThe Lancet Neurology, 2007
- Altered CD4+/CD8+ T-Cell Ratios in Cerebrospinal Fluid of Natalizumab-Treated Patients With Multiple SclerosisArchives of Neurology, 2006
- Immune reconstitution inflammatory syndrome in the CNS of HIV-infected patientsNeurology, 2006
- Evaluation of Patients Treated with Natalizumab for Progressive Multifocal LeukoencephalopathyNew England Journal of Medicine, 2006
- Reduced Rate of Diagnostic Positive Detection of JC Virus DNA in Cerebrospinal Fluid in Cases of Suspected Progressive Multifocal Leukoencephalopathy in the Era of Potent Antiretroviral TherapyJournal of Clinical Microbiology, 2005
- Progressive Multifocal Leukoencephalopathy in a Patient Treated with NatalizumabNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy Complicating Treatment with Natalizumab and Interferon Beta-1a for Multiple SclerosisNew England Journal of Medicine, 2005
- Progressive Multifocal Leukoencephalopathy after Natalizumab Therapy for Crohn's DiseaseNew England Journal of Medicine, 2005